Target intelligence / Profile preview

Family with sequence similarity 53 member A (FAM53A)

Target
FAM53A
Molecular classification
Other (uncharacterized protein, not a classical receptor/enzyme/transporter), possible transcriptional regulator interaction partner
01

Overview

Family with sequence similarity 53 member A (*FAM53A*) encodes a protein initially linked to neural development, particularly the specification of dorsal neural tube cell fate[1][2][3]. Recent research has revealed its involvement in cancer cell proliferation, migration, and invasion, with effects highly dependent on p53 tumor suppressor status: in p53 wild-type cells, FAM53A acts as a tumor suppressor by inhibiting MEK/ERK signaling and related cell growth and migration, whereas in p53-deficient cells, it can promote tumor progression by increasing MEK/ERK activity[2]. Genetics studies also associate FAM53A with Wolf-Hirschhorn syndrome and Blepharochalasis[1]. While FAM53A is not a classical drug target such as a receptor or kinase, its modulation of critical signaling pathways places it among emerging candidate targets for cancer therapy, biomarker development, and disease prognostication[2][10].

Other names
Protein FAM53ADNTNPDorsal neural-tube nuclear proteindorsal neural tube nuclear protein
02

Mechanism of action

For doxorubicin: FAM53A modulates the MEK/ERK pathway, influencing sensitivity and resistance depending on p53 status in breast cancer cells

03

Biological functions

Neural development (specifying dorsal neural tube cells)Protein import into the nucleusRegulation of cell proliferation and migration, especially in cancer contexts (MEK/ERK pathway modulation depending on p53 status)
04

Disease associations

Cancer (particularly breast cancer)Wolf-Hirschhorn syndrome (associated)Blepharochalasis (associated)
05

Safety considerations

None specific, due to limited direct therapeutic targeting evidence. However, role in cell proliferation implies potential risk of off-target effects if modulated
06

Interacting drugs

Doxorubicin
07

Biomarkers

Expression level of FAM53A (for patient selection and predicting doxorubicin sensitivity/resistance in breast cancer with specific p53 status)

Beyond the preview

Go deeper on Family with sequence similarity 53 member A (FAM53A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 53 member A (FAM53A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call